News About: Pharm. Industry
Exemption of anticancer drugs from targets of damage relief program for drug side effects
Anticancer drugs and immune disorder treatments have been exempted from targets of damage relief for drugside effects.
The Ministry of Food and Drug Safety (MFDS) made a public announcement on the 28th that several p...
Continuing decreases in stocks of pharmaceutical companies on the fourth quarter… market capital has dropped by 1.6%
Stocks of pharmaceutical companies in KOSPI have continued to decrease since the beginning of the fourth quarter.
According to the Daily Pharm’s analysis of market capitalization of 34 KOSPI pharmaceutical companies ...
Pharmaceutical companies’ co-marketing generates either ‘Jackpots’ or ‘Bankruptcies’
There is nothing new about co-marketing and co-promotion among pharmaceutical companies to be succeeded in certain product anymore. However, these types of cooperation do not guarantee success. The following are notic...
“Attractivepharmaceutical and biopharmaceutical companies that will be newly listed on December”
As 6 new pharmaceutical companies have waited to be newly listed on December, the industry analyzed that all of the companies are attractive for stock investors.
Al-eum Lee, an analyst of Hana Daetoo Securities Co., ...
The Celltrion’s biosimilar product ‘Remsima’acquired the drug price registration in JapanThe Celltrion’s biosimilar product ‘Remsima’has been registered in Japan.
Remsima has been included in the Japanese ‘Reported Items, Sinkit Product List’ (expected to be regist...
|
The positive forecast of ‘Sivextro’ expecting sales worth of $900 billion before 2019‘Sivextro (generic name: tedizolid)’, a super antibiotic developed by Dong-A ST, is positively forecasted to make the highest sales, including sales in the U.S. and Europe, wort...
|
A new global hypertension complex ‘Amosartan’ acquired a patent in JapanThe Hanmi Pharmaceutical’s (executive director Kwan-soon Lee)new global hypertension complex ‘Amosartan’has acquired a composite patent (application number: JP2011547746) in Jap...
|
The ‘cold’ atmosphere of job cuts among multinational pharmaceutical companies
As staff cuts among multinational pharmaceutical companies have been commonly noticed recently, salesmen in the companies have shown anxiety.
According to the industry on the 28th, as an American company has promoted...
Hanmi Pharmaceutical secureda patent for an inhalation asthma and COPD treatment ‘Fluterol’Hanmi Pharmaceutical (executive director Kwan-soon Lee)made a public announcement aboutacquisition of domestic patent on the self-developed inhalation asthma and COPD treatment ...
|
Among 1,000 pharmaceuticalproducts in Korea, 74% has the lowest price in OECD countries
There are about 1,000 pharmaceutical products of multinational pharmaceutical companies in the Korean market, and the average drug price in Korea is 44.4% cheaper than the average of what OECD countries have.
The Kor...
